PEG3350
PEG3350 is an FDA drug label for the active ingredient POLYETHYLENE GLYCOL 3350 manufactured by Major Pharmaceuticals administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20260828.
- Generic name
- POLYETHYLENE GLYCOL 3350
- Manufacturer
- Major Pharmaceuticals
- Product type
- HUMAN OTC DRUG
- Route
- ORAL
- Dosage form
- N/A
- NDC
- 0904-7534
- Application
- ANDA217505
- Label effective
- 20260828
About this product
PEG3350 is an FDA-registered drug product whose active ingredient is POLYETHYLENE GLYCOL 3350. It is labelled by Major Pharmaceuticals taken by oral and marketed as a human otc drug product. Identifiers on file: NDC 0904-7534, application ANDA217505, label effective 20260828. It is one of 45 FDA drug label records sharing the active ingredient POLYETHYLENE GLYCOL 3350. This page reproduces the FDA-approved label text so you can check what a product is, who makes it and how it is supplied before discussing it with a pharmacist or prescriber.
What it is used for
Across FDA labelling, products containing POLYETHYLENE GLYCOL 3350 are most often described in connection with: relieves occasional, constipation irregularity, generally produces, bowel movement. Wording differs between labels, and the full indications section on this page takes precedence when it is present.
Active ingredients
Indications & Usage
Use relieves occasional constipation (irregularity) generally produces a bowel movement in 1 to 3 days
Dosage & Administration
Directions do not take more than directed unless advised by your doctor adults and children 17 years of age and older: use once a day stir and dissolve one packet of powder (17 g) in any 4 to 8 ounces of beverage (cold, hot or room temperature) then drink do not combine with starch-based thickeners used for difficulty swallowing ensure that the powder is fully dissolved before drinking do not drink if there are any clumps do not use more than 7 days children 16 years of age or under: ask a doctor
Warnings
Warnings Allergy alert: Do not use if you are allergic to polyethylene glycol Do not use if you have kidney disease, except under the advice and supervision of a doctor Ask a doctor before use if you have nausea, vomiting or abdominal pain a sudden change in bowel habits that lasts over 2 weeks irritable bowel syndrome Ask a doctor or pharmacist before use if you are taking a prescription drug When using this product you may have loose, watery, more frequent stools Stop use and ask a doctor if you have rectal bleeding or your nausea, bloating, cramping or abdominal pain gets worse. These may be signs of a serious condition. you get diarrhea you need to use a laxative for longer than 1 week If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
More products with the same ingredient
POLYETHYLENE GLYCOL 3350365 WHOLE FOODS MARKET Polyethylene Glycol 3350
View labelCLEARLAX
View labelCLEARLAX
View labelCLEARLAX
View labelCOMFORTLAX
View labelEquate ClearLAX
View labelGAVILAX
View labelGAVILAX
View labelHow products containing POLYETHYLENE GLYCOL 3350 compare
FDA lists 45 drug label records with POLYETHYLENE GLYCOL 3350 as the active ingredient. The most common dosage forms and the manufacturers with the most records are summarised below; strengths, pack sizes and inactive ingredients can still differ between apparently similar products.
| Dosage form | Products | Manufacturer | Products |
|---|---|---|---|
| — | — | Amazon.com Services LLC | 4 |
| — | — | L. Perrigo Company | 3 |
| — | — | CVS Pharmacy | 2 |
| — | — | Cardinal Health 107, LLC | 2 |
| — | — | Major Pharmaceuticals | 2 |
Recall and safety notices
5 FDA recall record(s) match this product name or manufacturer. A match means the firm or product name appears in the enforcement report; confirm lot numbers and dates against the official FDA notice before acting.
| Recall | Product | Firm | Class | Status | Reported |
|---|---|---|---|---|---|
| D-0702-2026 | Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6951-61 | Major Pharmaceuticals | Class II | Ongoing | 20260729 |
| D-0709-2026 | Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. Distributed by Cardinal Health, Dublin, OH 43017. NDC Bag: 55154-3560-0; NDC Blister: 0904-6951-61 | Major Pharmaceuticals | Class II | Ongoing | 20260729 |
| D-0711-2026 | Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. Distributed by Cardinal Health, Dublin, OH 43017. NDC Bag: 55154-3563-0; NDC Blister: 0904-6956-61 | Major Pharmaceuticals | Class II | Ongoing | 20260729 |
| D-0703-2026 | Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6952-61 | Major Pharmaceuticals | Class II | Ongoing | 20260729 |
| D-0710-2026 | Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. Distributed by Cardinal Health, Dublin, OH 43017. NDC Bag: 55154-3562-0; NDC Blister: 0904-6951-61 | Major Pharmaceuticals | Class II | Ongoing | 20260729 |
Frequently asked questions
What is PEG3350 used for?
Use relieves occasional constipation (irregularity) generally produces a bowel movement in 1 to 3 days
Who makes PEG3350?
Major Pharmaceuticals is the labeler of record for PEG3350. 45 FDA label records share the active ingredient POLYETHYLENE GLYCOL 3350, so generic and branded versions may come from different companies; the manufacturer named on your pack is the one that matters for any enquiry.
What form does PEG3350 come in?
administered by oral. Strengths and pack sizes vary by label, so compare the NDC on your pack with the identifier listed on this page.
Is PEG3350 prescription or over-the-counter?
The FDA label for this product is recorded as human otc drug. Marketing status can differ between strengths and countries, so check the dispensing rules where you live.
Are there other products containing POLYETHYLENE GLYCOL 3350?
Yes. 45 FDA drug label records list POLYETHYLENE GLYCOL 3350 as the active ingredient. Products with the same active ingredient can usually be substituted only when a prescriber or pharmacist confirms it is appropriate.
Has PEG3350 been recalled?
5 FDA recall record(s) match this product name or manufacturer. Review the recall and safety notices section on this page and confirm lot numbers against the official FDA enforcement report.
Where does this information come from?
All content is reproduced from FDA Structured Product Labelling data via openFDA. It is provided for identification and reference only and is not medical advice.
This page reproduces FDA Structured Product Labelling data for identification and reference. It is not medical advice, does not diagnose or treat any condition, and does not sell or price any medicine.